Abstract
Spontaneous abortion has been a common obstetrical and gynecological disease, which occurs in 10–15% of all pregnancies. Recurrent miscarriage (RM) refers to the occurrence of three or more times abortions with the same partner. It is generally believed that environmental pollution associated with economic development may cause infertility and RM. When xenobiotics from the environment enter the body, they must be cleared from the body by various metabolic enzymes in the body. The absence or variation of these enzymes may be the genetic basis of RM caused by environmental pollution. The variation of metabolic detoxification enzyme can directly affect the removal of harmful substances from internal and external sources. Therefore, the determination of metabolic enzyme activity may become an important factor in the diagnosis of RM etiology and seeking methods to improve the detoxification ability has a great significance for the treatment of RM.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Eggo RPL, Bender Atik R, Christiansen OB, Elson J, Kolte AM, Lewis S, Middeldorp S, Nelen W, Peramo B, Quenby S, Vermeulen N, Goddijn M. ESHRE guideline: recurrent pregnancy loss. Hum Reprod Open. 2018;2018(2):4. https://doi.org/10.1093/hropen/hoy004.
Rai R, Regan L. Recurrent miscarriage. Lancet. 2006;368(9535):601–11. https://doi.org/10.1016/s0140-6736(06)69204-0.
Giudice LC. Environmental toxicants: hidden players on the reproductive stage. Fertil Steril. 2016;106(4):791–4. https://doi.org/10.1016/j.fertnstert.2016.08.019.
Sahoo T, Dzidic N, Strecker MN, Commander S, Travis MK, Doherty C, Tyson RW, Mendoza AE, Stephenson M, Dise CA, Benito CW, Ziadie MS, Hovanes K. Comprehensive genetic analysis of pregnancy loss by chromosomal microarrays: outcomes, benefits, and challenges. Genet Med. 2017;19(1):83–9. https://doi.org/10.1038/gim.2016.69.
Popescu F, Jaslow CR, Kutteh WH. Recurrent pregnancy loss evaluation combined with 24-chromosome microarray of miscarriage tissue provides a probable or definite cause of pregnancy loss in over 90% of patients. Hum Reprod. 2018;33(4):579–87. https://doi.org/10.1093/humrep/dey021.
Shahine L, Lathi R. Recurrent pregnancy loss: evaluation and treatment. Obstet Gynecol Clin N Am. 2015;42(1):117–34. https://doi.org/10.1016/j.ogc.2014.10.002.
Li J, Li X, Zhang S, Snyder M. Gene-environment interaction in the era of precision medicine. Cell. 2019;177(1):38–44. https://doi.org/10.1016/j.cell.2019.03.004.
Egerup P, Kolte AM, Larsen EC, Krog M, Nielsen HS, Christiansen OB. Recurrent pregnancy loss: what is the impact of consecutive versus non-consecutive losses? Hum Reprod. 2016;31(11):2428–34. https://doi.org/10.1093/humrep/dew169.
Silva TL, Carneiro PLS, Ambrosini DP, Lôbo RB, Filho RM, Malhado CHM. Genotype-environment interaction in the genetic variability analysis of reproductive traits in Nellore cattle. Livest Sci. 2019;230:103825. https://doi.org/10.1016/j.livsci.2019.103825.
Toth B, Jeschke U, Rogenhofer N, Scholz C, Würfel W, Thaler CJ, Makrigiannakis A. Recurrent miscarriage: current concepts in diagnosis and treatment. J Reprod Immunol. 2010;85(1):25–32. https://doi.org/10.1016/j.jri.2009.12.006.
Major J, Jakab MG, Tompa A. The frequency of induced premature centromere division in human populations occupationally exposed to genotoxic chemicals. Mutat Res. 1999;445(2):241–9. https://doi.org/10.1016/s1383-5718(99)00129-1.
Economopoulos KP, Sergentanis TN. GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: a comprehensive meta-analysis. Eur J Cancer. 2010;46(9):1617–31. https://doi.org/10.1016/j.ejca.2010.02.009.
Nonaka T, Takakuwa K, Tanaka K. Analysis of the polymorphisms of genes coding biotransformation enzymes in recurrent miscarriage in the Japanese population. J Obstet Gynaecol Res. 2011;37(10):1352–8. https://doi.org/10.1111/j.1447-0756.2011.01529.x.
Polimanti R, Piacentini S, Lazzarin N, Vaquero E, Re MA, Manfellotto D, Fuciarelli M. Glutathione S-transferase genes and the risk of recurrent miscarriage in Italian women. Fertil Steril. 2012;98(2):396–400. https://doi.org/10.1016/j.fertnstert.2012.05.003.
Zusterzeel PL, Nelen WL, Roelofs HM, Peters WH, Blom HJ, Steegers EA. Polymorphisms in biotransformation enzymes and the risk for recurrent early pregnancy loss. Mol Hum Reprod. 2000;6(5):474–8. https://doi.org/10.1093/molehr/6.5.474.
Meech R, Hu DG, McKinnon RA, Mubarokah SN, Haines AZ, Nair PC, Rowland A, Mackenzie PI. The UDP-glycosyltransferase (UGT) superfamily: new members, new functions, and novel paradigms. Physiol Rev. 2019;99(2):1153–222. https://doi.org/10.1152/physrev.00058.2017.
Mackenzie PI, Owens IS, Burchell B, Bock KW, Bairoch A, Bélanger A, Fournel-Gigleux S, Green M, Hum DW, Iyanagi T, Lancet D, Louisot P, Magdalou J, Chowdhury JR, Ritter JK, Schachter H, Tephly TR, Tipton KF, Nebert DW. The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics. 1997;7(4):255–69. https://doi.org/10.1097/00008571-199708000-00001.
Zhang Y, Hou J, Feng F, Li D, Jiang Q, Li X, Zhao Q, Li BA. Genetic polymorphisms in human UDP-glucuronosyltransferases 1A7 and the risk of gastrointestinal carcinomas: a systematic review and network meta-analysis. Oncotarget. 2017;8(39):66371–81. https://doi.org/10.18632/oncotarget.18675.
Petrenaite V, Öhman I, Ekström L, Sæbye D, Hansen TF, Tomson T, Sabers A. UGT polymorphisms and lamotrigine clearance during pregnancy. Epilepsy Res. 2018;140:199–208. https://doi.org/10.1016/j.eplepsyres.2018.01.011.
Reisinger TL, Newman M, Loring DW, Pennell PB, Meador KJ. Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy. Epilepsy Behav. 2013;29(1):13–8. https://doi.org/10.1016/j.yebeh.2013.06.026.
Li SN, Cao YF, Sun XY, Yang K, Liang YJ, Gao SS, Fu ZW, Liu YZ, Yang K, Fang ZZ. Hydroxy metabolites of polychlorinated biphenyls (OH-PCBs) exhibit inhibitory effects on UDP-glucuronosyltransferases (UGTs). Chemosphere. 2018;212:513–22. https://doi.org/10.1016/j.chemosphere.2018.08.040.
Wang F, Wang S, Yang K, Liu YZ, Yang K, Chen Y, Fang ZZ. Inhibition of UDP-glucuronosyltransferases (UGTs) by bromophenols (BPs). Chemosphere. 2020;238:124645. https://doi.org/10.1016/j.chemosphere.2019.124645.
Kapitulnik J. Bilirubin: an endogenous product of heme degradation with both cytotoxic and cytoprotective properties. Mol Pharmacol. 2004;66(4):773–9. https://doi.org/10.1124/mol.104.002832.
Servedio V, d’Apolito M, Maiorano N, Minuti B, Torricelli F, Ronchi F, Zancan L, Perrotta S, Vajro P, Boschetto L, Iolascon A. Spectrum of UGT1A1 mutations in Crigler-Najjar (CN) syndrome patients: identification of twelve novel alleles and genotype-phenotype correlation. Hum Mutat. 2005;25(3):325. https://doi.org/10.1002/humu.9322.
Itäaho K, Mackenzie PI, Ikushiro S, Miners JO, Finel M. The configuration of the 17-hydroxy group variably influences the glucuronidation of beta-estradiol and epiestradiol by human UDP-glucuronosyltransferases. Drug Metab Dispos. 2008;36(11):2307–15. https://doi.org/10.1124/dmd.108.022731.
Guillemette C. Pharmacogenomics of human UDP-glucuronosyltransferase enzymes. Pharmacog J. 2003;3(3):136–58. https://doi.org/10.1038/sj.tpj.6500171.
Mackenzie PI, Miners JO, McKinnon RA. Polymorphisms in UDP glucuronosyltransferase genes: functional consequences and clinical relevance. Clin Chem Lab Med. 2000;38(9):889–92. https://doi.org/10.1515/cclm.2000.129.
Nagar S, Remmel RP. Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer. Oncogene. 2006;25(11):1659–72. https://doi.org/10.1038/sj.onc.1209375.
Ménard V, Eap O, Harvey M, Guillemette C, Lévesque E. Copy-number variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional polymorphism. Hum Mutat. 2009;30(9):1310–9. https://doi.org/10.1002/humu.21054.
Lewis BC, Mackenzie PI, Elliot DJ, Burchell B, Bhasker CR, Miners JO. Amino terminal domains of human UDP-glucuronosyltransferases (UGT) 2B7 and 2B15 associated with substrate selectivity and autoactivation. Biochem Pharmacol. 2007;73(9):1463–73. https://doi.org/10.1016/j.bcp.2006.12.021.
Stringer F, Scott G, Valbuena M, Kinley J, Nishihara M, Urquhart R. The effect of genetic polymorphisms in UGT2B15 on the pharmacokinetic profile of sipoglitazar, a novel anti-diabetic agent. Eur J Clin Pharmacol. 2013;69(3):423–30. https://doi.org/10.1007/s00228-012-1382-7.
Hanioka N, Naito T, Narimatsu S. Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation. Chemosphere. 2008;74(1):33–6. https://doi.org/10.1016/j.chemosphere.2008.09.053.
Hunt PA, Lawson C, Gieske M, Murdoch B, Smith H, Marre A, Hassold T, VandeVoort CA. Bisphenol A alters early oogenesis and follicle formation in the fetal ovary of the rhesus monkey. Proc Natl Acad Sci U S A. 2012;109(43):17525–30. https://doi.org/10.1073/pnas.1207854109.
Kong D, Xing L, Liu R, Jiang J, Wang W, Shang L, Wei X, Hao W. Individual and combined developmental toxicity assessment of bisphenol A and genistein using the embryonic stem cell test in vitro. Food Chem Toxicol. 2013;60:497–505. https://doi.org/10.1016/j.fct.2013.08.006.
Jiang HM, Fang ZZ, Cao YF, Hu CM, Sun XY, Hong M, Yang L, Ge GB, Liu Y, Zhang YY, Dong Q, Liu RJ. New insights for the risk of bisphenol A: inhibition of UDP-glucuronosyltransferases (UGTs). Chemosphere. 2013;93(6):1189–93. https://doi.org/10.1016/j.chemosphere.2013.06.070.
Nishikawa M, Iwano H, Yanagisawa R, Koike N, Inoue H, Yokota H. Placental transfer of conjugated bisphenol A and subsequent reactivation in the rat fetus. Environ Health Perspect. 2010;118(9):1196–203. https://doi.org/10.1289/ehp.0901575.
Tampal N, Lehmler HJ, Espandiari P, Malmberg T, Robertson LW. Glucuronidation of hydroxylated polychlorinated biphenyls (PCBs). Chem Res Toxicol. 2002;15(10):1259–66. https://doi.org/10.1021/tx0200212.
Wang D. The uridine diphosphate glucuronosyltransferases: quantitative structure-activity relationships for hydroxyl polychlorinated biphenyl substrates. Arch Toxicol. 2005;79(10):554–60. https://doi.org/10.1007/s00204-005-0671-7.
Net S, Delmont A, Sempéré R, Paluselli A, Ouddane B. Reliable quantification of phthalates in environmental matrices (air, water, sludge, sediment and soil): a review. Sci Total Environ. 2015;515:162–80. https://doi.org/10.1016/j.scitotenv.2015.02.013.
Harris S, Wegner S, Hong SW, Faustman EM. Phthalate metabolism and kinetics in an in vitro model of testis development. Toxicol In Vitro. 2016;32:123–31. https://doi.org/10.1016/j.tiv.2015.12.002.
Ito R, Seshimo F, Miura N, Kawaguchi M, Saito K, Nakazawa H. Effect of sterilization process on the formation of mono(2-ethylhexyl)phthalate from di(2-ethylhexyl)phthalate. J Pharm Biomed Anal. 2006;41(2):455–60. https://doi.org/10.1016/j.jpba.2005.12.021.
Huang PC, Kuo PL, Guo YL, Liao PC, Lee CC. Associations between urinary phthalate monoesters and thyroid hormones in pregnant women. Hum Reprod. 2007;22(10):2715–22. https://doi.org/10.1093/humrep/dem205.
Lovekamp TN, Davis BJ. Mono-(2-ethylhexyl) phthalate suppresses aromatase transcript levels and estradiol production in cultured rat granulosa cells. Toxicol Appl Pharmacol. 2001;172(3):217–24. https://doi.org/10.1006/taap.2001.9156.
Zheng B, Hu G, Yu J, Liu Z. Crigler-Najjar syndrome type II in a Chinese boy resulting from three mutations in the bilirubin uridine 5′-diphosphate-glucuronosyltransferase (UGT1A1) gene and a family genetic analysis. BMC Pediatr. 2014;14:267. https://doi.org/10.1186/1471-2431-14-267.
Du Z, Cao YF, Li SN, Hu CM, Fu ZW, Huang CT, Sun XY, Liu YZ, Yang K, Fang ZZ. Inhibition of UDP-glucuronosyltransferases (UGTs) by phthalate monoesters. Chemosphere. 2018;197:7–13. https://doi.org/10.1016/j.chemosphere.2018.01.010.
ACOG Practice Bulletin No.142. Cerclage for the management of cervical insufficiency. Obstet Gynecol. 2014;123(2 Pt 1):372–9. https://doi.org/10.1097/01.AOG.0000443276.68274.cc.
Cao Y, Sun H, Zhu H, Zhu X, Tang X, Yan G, Wang J, Bai D, Wang J, Wang L, Zhou Q, Wang H, Dai C, Ding L, Xu B, Zhou Y, Hao J, Dai J, Hu Y. Allogeneic cell therapy using umbilical cord MSCs on collagen scaffolds for patients with recurrent uterine adhesion: a phase I clinical trial. Stem Cell Res Ther. 2018;9(1):192. https://doi.org/10.1186/s13287-018-0904-3.
Glueck CJ, Smith D, Gandhi N, Hemachandra K, Shah P, Wang P. Treatable high homocysteine alone or in concert with five other thrombophilias in 1014 patients with thrombotic events. Blood Coagul Fibrinolysis. 2015;26(7):736–42. https://doi.org/10.1097/mbc.0000000000000276.
De Krom G, Arens YH, Coonen E, Van Ravenswaaij-Arts CM, Meijer-Hoogeveen M, Evers JL, Van Golde RJ, De Die-Smulders CE. Recurrent miscarriage in translocation carriers: no differences in clinical characteristics between couples who accept and couples who decline PGD. Hum Reprod. 2015;30(2):484–9. https://doi.org/10.1093/humrep/deu314.
Andrade C. Major malformation risk, pregnancy outcomes, and neurodevelopmental outcomes associated with metformin use during pregnancy. J Clin Psychiatry. 2016;77(4):e411–4. https://doi.org/10.4088/JCP.16f10789.
Empson M, Lassere M, Craig J, Scott J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev. 2005;2:Cd002859. https://doi.org/10.1002/14651858.CD002859.pub2.
Alijotas-Reig J, Ferrer-Oliveras R. The European registry on obstetric antiphospholipid syndrome (EUROAPS): a preliminary first year report. Lupus. 2012;21(7):766–8. https://doi.org/10.1177/0961203312440058.
Chouinard S, Yueh MF, Tukey RH, Giton F, Fiet J, Pelletier G, Barbier O, Bélanger A. Inactivation by UDP-glucuronosyltransferase enzymes: the end of androgen signaling. J Steroid Biochem Mol Biol. 2008;109(3-5):247–53. https://doi.org/10.1016/j.jsbmb.2008.03.016.
Bock KW. From differential induction of UDP-glucuronosyltransferases in rat liver to characterization of responsible ligand-activated transcription factors, and their multilevel crosstalk in humans. Biochem Pharmacol. 2011;82(1):9–16. https://doi.org/10.1016/j.bcp.2011.03.011.
Michels AJ, Hagen TM, Frei B. Human genetic variation influences vitamin C homeostasis by altering vitamin C transport and antioxidant enzyme function. Annu Rev Nutr. 2013;33:45–70. https://doi.org/10.1146/annurev-nutr-071812-161246.
Ikeda S, Abe C, Uchida T, Ichikawa T, Horio F, Yamashita K. Dietary sesame seed and its lignan increase both ascorbic acid concentration in some tissues and urinary excretion by stimulating biosynthesis in rats. J Nutr Sci Vitaminol. 2007;53(5):383–92. https://doi.org/10.3177/jnsv.53.383.
Berger ND, Stanley FKT, Moore S, Goodarzi AA. ATM-dependent pathways of chromatin remodelling and oxidative DNA damage responses. Philos Trans R Soc Lond Ser B Biol Sci. 2017;372:1731. https://doi.org/10.1098/rstb.2016.0283.
Tanaka T, Kobori Y, Terai K, Inoue Y, Osaka A, Yoshikawa N, Shimomura Y, Suzuki K, Minami T, Iwahata T, Onota S, Yamamoto A, Sugimoto K, Okada H. Seminal oxidation-reduction potential and sperm DNA fragmentation index increase among infertile men with varicocele. Hum Fertil. 2020;2020:1–5. https://doi.org/10.1080/14647273.2020.1712747.
Neusser M, Rogenhofer N, Dürl S, Ochsenkühn R, Trottmann M, Jurinovic V, Steinlein O, von Schönfeldt V, Müller S, Thaler CJ. Increased chromosome 16 disomy rates in human spermatozoa and recurrent spontaneous abortions. Fertil Steril. 2015;104(5):1130–7. https://doi.org/10.1016/j.fertnstert.2015.07.1160.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Song, C., Shang, W. (2021). The Variations of Metabolic Detoxification Enzymes Lead to Recurrent Miscarriage and Their Diagnosis Strategy. In: Zhang, H., Yan, J. (eds) Environment and Female Reproductive Health. Advances in Experimental Medicine and Biology, vol 1300. Springer, Singapore. https://doi.org/10.1007/978-981-33-4187-6_12
Download citation
DOI: https://doi.org/10.1007/978-981-33-4187-6_12
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-33-4186-9
Online ISBN: 978-981-33-4187-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)